Safety and efficacy of nivolumab, an anti-PD1 immunotherapy, in patients with advanced basal cell carcinoma, after failure or intolerance to sonic Hedgehog inhibitors: UNICANCER AcSé NIVOLUMAB trial
Titel:
Safety and efficacy of nivolumab, an anti-PD1 immunotherapy, in patients with advanced basal cell carcinoma, after failure or intolerance to sonic Hedgehog inhibitors: UNICANCER AcSé NIVOLUMAB trial
Auteur:
Véron, Marie Chevret, Sylvie Grob, Jean-Jacques Beylot-Barry, Marie Saiag, Philippe Fléchon, Aude You, Benoit Maubec, Eve Jouary, Thomas Toulemonde, Elise Jamme, Philippe Gambotti, Laëtitia Lamrani-Ghaouti, Assia Dupuy, Alain Lebbe, Céleste Seguin, Nicole Basset Houede, Nadine Leccia, Marie-Thérèse Le Du, Fanny de Pontville, Michel Gaudy-Marquestre, Caroline Guillot, Bernard Simon, Clotilde Marabelle, Aurélien Mortier, Laurent